Effectiveness of vestibular electrical stimulation combined with vestibular rehabilitation in chronic unilateral vestibular hypofunction: A randomized controlled trial Authors: Bilal Burak Bayraklı, Canan Çelik, Ömer Kuzu, Özlem Öztürk Tan Published: 2026 ABSTRACT ObjectivesTo evaluate the effectiveness of vestibular electrical stimulation (VES) combined with vestibular rehabilitation (VR) in patients with chronic unilateral vestibular hypofunction (UVH).Patients and MethodsForty patients aged 18-65 years, diagnosed with UVH, were randomized into two groups. Participants underwent a 4-week intervention: the VR group received supervised VR, whereas the VR+VES group received VES in addition to supervised VR. The groups were evaluated before and after treatment, including the dizziness handicap inventory (DHI), visual analogue scale (VAS), Berg balance scale (BBS), timed up-and-go test (TUG), activity-specific balance and confidence scale (ABCs), Beck anxiety inventory (BAI), Beck depression inventory (BDI), and static posturography.ResultsThirty-eight of 40 enrolled patients (95%) completed the study. Statistically significant improvements were observed in DHI, VAS, BBS, and ABCs scores in both groups after treatment (p<0.05). Additionally, the VR+VES group showed significant improvements in TUG, BAI, BDI, and right-sided limits of stability (p<0.05).ConclusionSupervised VR effectively improved dizziness severity, balance, and functional status in patients with chronic UVH. The addition of VES to supervised VR further enhanced postural stability, reduced the risk of falls, and alleviated symptoms of anxiety and depression. Vestibular hypofunction (VH) is a condition affecting the vestibular reflexes resulting from reduced or absent function of the vestibular organs and vestibular nerve.[1] VH can be unilateral or bilateral. In chronic cases, compensation and adaptation mechanisms do not function properly and clinical normalization cannot occur; consequently, persistent imbalance and dizziness may lead to an increased risk of falls, restricted daily activities, and a permanent psychosocial burden.[2, 3] A recently published clinical guideline includes strong recommendations for supervised vestibular rehabilitation (VR) for patients with chronic unilateral vestibular hypofunction (UVH). The aim is to improve the functional status of patients by facilitating vestibular compensation. This is achieved using specific interventions: habituation exercises that progressively reduce motion sensitivity through controlled exposure, gaze stabilization tasks that recalibrate the vestibulo-ocular reflex (VOR) to maintain clear vision during head movements, and balance training that enhances spatial orientation and functional postural strategies.[2] Three systems play a role in dynamic head balance control: the vestibular system, the visual system, and the proprioceptive system, which optimizes vestibulospinal control. Vestibulospinal reflexes play an active role in maintaining postural sway. Furthermore, the correct head position is controlled by the vestibulocollic and cervical reflexes.[3] In addition to VR, vestibular electrical stimulation (VES) has been suggested for use in the treatment of vestibular disorders since 1990.[4] Transcutaneous electrical nerve stimulation (TENS)-mediated VES increases the excitability of these reflexes and contributes to compensation with input similar to the cervical and spinal reflex effect.[5] Like the non-invasive use of galvanic vestibular stimulation for VES, TENS, based on the principle of stimulating nerves and muscles via surface electrodes, is also used in the treatment of vestibular dysfunctions.[6] In TENS-mediated VES applications, asymmetric and modulated biphasic square wave currents with an average frequency of 80 Hz and a duration of 100 µs are used.[7] This frequency is within the activation range of the vibration muscle spindles, and it is possible for this intervention to stimulate the same spinal pathways as the cervicospinal pathway. The changes resulting from the transmission of these signals may provide better perception and control of body and head positions via proprioceptive signals.[3] Although previous studies have shown that supervised VR and VES (TENS and galvanic vestibular stimulation) are effective in patients with VH, to the best of our knowledge, there is no study evaluating the effectiveness of the combined application of these two treatment methods in patients with chronic UVH.[5, 7, 8] This study aimed to investigate the effects of TENS-mediated VES applied with a supervised rehabilitation program on functional results, balance function, stability, anxiety and depression in patients with chronic UVH. PATIENTS AND METHODS Study design and participants This prospective, randomized controlled, open-label trial was conducted at a tertiary hospital between 2023 and 2024. Inclusion criteria required participants to be 18-65 years of age, to have been evaluated by an otorhinolaryngologist, a neurologist, and a physical medicine and rehabilitation specialist, and to have findings consistent with chronic UVH (symptom duration >3 months) and a VOR gain of less than 0.7 for unilateral semicircular canal based on the video head impulse test. Patients were excluded if they had neurological or psychiatric disorders, were using vestibular suppressant drugs, had a history of stroke, head trauma, other neurological diseases, or brain surgery; had severely limited neck joint range of motion (those with a limitation of 45 degrees or more). The study was conducted after approval from the Ankara Bilkent City Hospital Ethics Committee (decision no: E2-22-2962, date: 23.12.2022). The study was performed according to the Declaration of Helsinki. Written informed consent was obtained from all patients prior to their participation (ClinicalTrials.gov ID: NCT06563076). In this study, a total of 68 patients were evaluated for eligibility; 18 did not meet the inclusion criteria, and 10 declined to participate. Forty patients who met the inclusion criteria and agreed to participate were included in the study. Following the baseline assessment, eligible patients were randomly assigned in a 1:1 ratio to either the VR or VR+VES group using a computer-generated randomization sequence. Figure 1 demonstrates the CONSORT diagram for the participants. Group 1 (VR group, n=20) received 3 sessions of supervised VR per week for 4 weeks. Group 2 (VR+VES group, n=20) received 3 sessions of supervised VR and TENS-mediated VES per week for 4 weeks. One patient from group 1 and one patient from group 2 were discontinued due to treatment disruption. Treatment protocols The VR program consisted of gaze stabilization exercises, habituation exercises, balance-coordination exercises, and postural stabilization exercises. Patients participated in the VR program three times per week, with each session lasting 60 minutes, completing a total of 12 sessions over a four-week period under the supervision of the same physiatrist and physiotherapist. Since the treatment was fully supervised in a clinical setting, patient compliance and adherence to the VR protocol were monitored through session attendance logs. Group 2 received TENS-mediated VES in addition to the VR program, administered by the same physiatrist and physiotherapist. In the VR+VES group, VES was performed throughout the rehabilitation period using a single bipolar channel with 2 electrodes using a TENS device (NeuroTrac® MyoPlus Pro Brand EMG, ETS and TENS Device, Tagoat, Co. Wexford, Ireland). For stimulation, biphasic square wave impulses with a frequency of 80 Hz and an average current pulse duration of 100 µs, which do not cause muscle contraction, were applied throughout the session. Stimulation was provided by two surface electrodes of 2 cm2 size fixed to the skin with adhesive tape. The electrodes were placed on the contralateral C2-C3 paravertebral and ipsilateral trapezius muscle motor point, relative to the side of the VH. Clinical assessment The patients’ age, sex, body mass index, comorbidities, smoking, and duration of dizziness were recorded. All patients were assessed immediately before and at the end of treatment using the measurements reported below. Functionality: The “dizziness handicap inventory (DHI)”, consisting of 25 items that determine the functional and sensory consequences of vestibular system diseases, was used. Each question is scored as yes (4 points), no (0 points), and sometimes (2 points). High scores indicate that the individual’s dizziness complaint interferes with life to a high degree.[9] Severity of dizziness: The severity of dizziness was assessed using a standard 10-cm visual analogue scale (VAS), with 0 at one end indicating “no symptoms” and 10 at the other end indicating “very severe symptoms”.[10] Risk of falling: Functional mobility and fall risk in patients were assessed with a timed up-and-go (TUG) test. Patients were asked to stand up from a standard chair without using their arms, walk a distance of 3 meters at a comfortable and safe pace, turn around, walk back, and sit down. The total time required to complete this sequence was measured in seconds using a stopwatch. It is accepted that the risk of falling increases as the duration of the timed up-and-go test increases.[11] Balance: The “Berg balance scale (BBS)” is a scale that shows whether patients can maintain their balance while performing 14 different tasks. Each task is scored from 0 (cannot perform) to 4 (performs safely). The maximum score is 56. Low scores indicate that the person is out of balance.[12] Self-confidence during the activity: The confidence that patients felt during their daily living activities was assessed with the “activity specific balance confidence scale (ABC)”. It consists of 16 questions and each question is given a score between 0 (having no confidence at all) and 100 (having full confidence). As the ratio decreases, it indicates that the person’s self-confidence during the activity decreases.[13] Depression: The Beck depression inventory (BDI) was used to measure severity of depression symptoms. It consists of 21 questions and each question is scored from 0 to 3, resulting in a total score of 0 to 63. Higher scores indicate an increased risk of depression.[14] Anxiety: The Beck anxiety inventory (BAI) was used to measure the severity of anxiety symptoms. It is a self-report scale consisting of 21 items and scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate an increased risk of anxiety.[15] Stability in standing position: The “limits of stability (LOS)” test, which measures the maximum limit at which people can stand when leaning in certain directions in order to remain stable to maintain balance, was evaluated with the Hur Smart Balance (SME Inc, USA) Static Posturography device. Individuals were asked to step onto the device’s platform with bare feet. This protocol was used to test the stability limits of the individual in four directions. Statistical analysis The sample size was calculated using G*Power, software (version 3.1.9.6) based on the DHI as the primary outcome measure. To detect a statistically significant difference in DHI scores between the treatment groups with 90% power and a 5% significance level (α=0.05), and to compensate for a potential dropout rate of 10% during the follow-up period, a total sample size of 40 patients (20 per group) was determined. Statistical analyses were performed using SPSS 24.0 (IBM Corp., Armonk, NY, USA). The Kolmogorov-Smirnov test was used to check whether the data were normally distributed. Continuous variables were expressed as mean ± standard deviation for normally distributed data or as median (25-75%) for non-normally distributed data. Categorical variables were expressed as numbers (%). Pearson chi-square test and Fisher’s exact test were used to compare independent categorical variables. Within-group comparisons (pre- versus post-treatment) were performed using the Wilcoxon signed-rank test for non-normally distributed numerical data. For the comparison of efficacy between the two groups, an analysis of covariance (ANCOVA) approach was utilized as the primary analysis, modeling the change score (Δ) adjusted for the baseline pre-treatment score (Δ ~ group + pre). Model fit and necessary assumptions were evaluated by inspecting residuals for normality, homoscedasticity, outliers, and influential points. For variables that failed to meet these parametric assumptions, the Mann-Whitney U test was employed to compare the change scores between the groups. A p value of <0.05 was considered statistically significant. RESULTS In the present study, 40 patients who met all criteria were randomly assigned to either the VR group (n=20) or the VR+VES group (n=20). During the 4-week intervention, 1 patient from each group discontinued the treatment program voluntarily. Ultimately, 38 patients completed the study (19 in the VR group and 19 in the VR+VES group). The detailed CONSORT flow diagram for the participants is presented in Figure 1. Demographic and clinical data of both groups are summarized in Table 1, and baseline demographic and clinical characteristics were similar between the groups (Table 1). Table 2 shows the intragroup results of clinical parameters. Both groups demonstrated significant post-treatment improvements in DHI, VAS, BBS, and ABC scores (p<0.05). Only the VR+VES group showed additional significant gains in TUG, BAI, BDI, and right-sided LOS values (Table 2). Table 3 shows the between-group comparisons for the change scores (Δ) across all clinical parameters. When these change scores were evaluated (using ANCOVA adjusted for baseline scores or the Mann-Whitney U test, depending on data distribution), no statistically significant differences were found between the two groups (p>0.05) (Table 3). No adverse events or treatment-related complications were reported. DISCUSSION The present study evaluated the effectiveness of VES combined with supervised VR in patients with chronic UVH. The main findings demonstrate that supervised VR was effective in improving functionality, dizziness severity, and balance function and beneficial effects were also observed in terms of fall risk, depression and anxiety levels, and right-sided LOS when supervised VR was combined with VES. Regarding the underlying mechanisms, the vestibular system and the cervical proprioceptive system have a complementary structure. The first three cervical vertebrae play an important role in daily head movements, and projections from these roots to the inferior vestibular nucleus have been described. It has been hypothesized that electrical stimulation of the cervical roots and vestibular nerve may act via the spinovestibular and cervicospinal pathways and have an effect on cervicospinal reflexes and proprioceptive mechanisms.[3, 16] There are publications in the literature evaluating the effect of TENS in different vestibular pathologies and comparing TENS with galvanic vestibular stimulation.[5, 6, 7] Non-invasive methods such as TENS-mediated VES and galvanic VES affect the vestibular afferent system with similar effects in principle.[7] Barozzi et al.[5] divided 28 patients with chronic unilateral hypofunction into two groups; they applied oculomotor exercises to one group and VES to the other group via surface electrodes with TENS at a stimulation duration of 100 µs and frequency of 80 Hz on the opposite side of the affected side. DHI scores improved significantly in both groups and when the two groups were compared, no significant difference was observed in DHI scores.[5] In the present study, similar to the Barozzi method, a TENS device and surface electrodes were used for stimulation at a duration of 100 µs and a frequency of 80 Hz. Significant improvements were recorded in DHI total and VAS scores in both VR and VR+VES groups after treatment. The results of the present study emphasize the importance of supervised VR. The positive results obtained in terms of functionality and dizziness severity in both groups can be interpreted as a result of the supervised implementation of VR and the increased compliance of patients to treatment due to supervision. Some randomized controlled trials have evaluated the effects of different treatment methods on balance function and fall risk in patients with UVH.[16, 17, 18, 19] To our knowledge, there is no study in the literature evaluating the effect of TENS-mediated VES on balance function and fall risk with TUG, BBS and ABCs in chronic UVH. In the present study, BBS and ABC parameters showed significant improvements in both groups. While no significant improvement was observed in TUG scores in the VR group, significant improvement was noted in the VR+VES group. As a result, while both treatment programs provided positive improvements in balance function in patients, VES-combined treatment showed within-group improvements in fall risk parameters; however, between-group comparisons did not achieve statistical significance. It is known that LOS are affected in VH. In a recent study, the results of VR treatment in patients with VH were evaluated with static posturography,[20] while in another study, it was determined that the LOS results in static posturography of patients with UVH were significantly affected in certain directions.[21] In the present study, while LOS values ​​showed no significant difference in the VR group, right LOS values ​​improved significantly in the VR+VES group. This specific improvement indicates that TENS-mediated VES has beneficial effects on stability. The positive results obtained in terms of fall risk and stability suggest that TENS-mediated VES not only stimulates spinovestibular and cervicospinal pathways, but also facilitates a synergistic effect of augmented proprioceptive feedback and enhanced sensory reweighting. Dizziness, vertigo and balance disorders due to VH may cause anxiety, depression and restlessness in patients.[22] Ayar et al.[23] found that anxiety and depression levels were significantly elevated in patients with acute UVH, and some studies have reported significant improvements in these psychosocial parameters as a result of VR treatment.[24] In the present study, while no significant difference was found in the post-treatment BAI and BDI scores in the VR group, significant improvements were recorded in the VR+VES group. Regarding the underlying mechanisms, some studies have shown that VES can induce neurochemical changes in the striatum and exert a neuromodulatory effect.[25] As a result, while the decrease in anxiety and depression levels observed in our study is primarily attributed to prominent symptom reduction and increased self-confidence, the potential neuromodulatory effects of VES on the striatum may also contribute as a secondary mechanism requiring further neurophysiological confirmation. The present study has several limitations, including a relatively small sample size, a single-center design, and the lack of long-term follow-up data. Furthermore, the absence of a placebo control group and the open-label design of the study should be taken into account when interpreting these results. The results of this study indicate that supervised VR improves functionality, dizziness severity, and balance function in patients with chronic UVH, and VES combined with supervised VR has additional benefits in improving fall risk, stability, anxiety, and depression levels. Future comprehensive studies with long-term follow-up are needed to further evaluate the effectiveness of VES in patients with chronic UVH by comparing different treatment modalities, investigating the dose-response relationship, and exploring neurophysiological correlations (e.g., using vestibular evoked myogenic potentials or functional neuroimaging).